Tempest Therapeutics Inc (TPST): Long hold. Roche wouldn't supply them wi...

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	10
Posts	871
Boards Moderated	0
Alias Born	08/31/2024

aBeezlee

Re: None

Monday, 10/28/2024 2:34:15 PM

Monday, October 28, 2024 2:34:15 PM

Long hold. Roche wouldn't supply them with goods if they felt phase 3 would fail. Looking for $2 on positive results.

Bullish

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent TPST News

Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/29/2026 09:06:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2026 09:01:10 PM
Tempest Therapeutics Announces Warrant Exercise for Approximately $2 Million in Gross Proceeds • GlobeNewswire Inc. • 05/29/2026 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2026 09:28:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2026 09:05:53 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 09:03:49 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2026 08:28:56 PM
Tempest Reports First Quarter 2026 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/14/2026 08:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 11:45:44 AM
Tempest Presents Clinical Update at ISCT 2026 Annual Meeting • GlobeNewswire Inc. • 05/06/2026 11:00:00 AM
Tempest to Advance Dual-Targeting CAR-T Platform with Clinical Update at ISCT 2026 Annual Meeting • GlobeNewswire Inc. • 04/29/2026 12:00:00 PM
Tempest Announces Key Manufacturing Milestone for TPST-2003 Dual-Targeting CD19/BCMA CAR-T • GlobeNewswire Inc. • 04/22/2026 12:00:00 PM
Tempest Appoints Andrew Fang, Ph.D., as Head of Business Development to Advance Strategic Partnerships and Global Licensing Efforts • GlobeNewswire Inc. • 04/14/2026 12:00:00 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/10/2026 01:25:54 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/10/2026 01:24:42 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/10/2026 04:15:15 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:00:36 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 04/02/2026 01:50:03 AM
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 03/31/2026 10:01:25 AM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/30/2026 09:57:12 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/30/2026 09:55:59 PM
Tempest Reports Year End 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/30/2026 01:00:00 PM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent TPST News

More TPST News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent TPST News

Go Ad-Free